Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cisplatin (platinol) (1 trial)
fluorouracil (efudex) (1 trial)
tyrosine kinase inhibitor (1 trial)
vitamin c (2 trials)
Ascites (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Yang Deficiency (Phase 2)
Yin Deficiency (Phase 2)
Trials (3 total)
Trial APIs (4 total)